Myriad Genetics |
Datum/Zeit | / |
Diff. / Diff.(%) | - / |
Geld | - |
Brief | - |
Eröffnung | - |
Schluss Vortag | - |
Tageshoch | - |
Tagestief | - |
Volumen [USD] | - |
Volumen [Stück] | |
Preisfeststellungen | |
ISIN | US62855J1043 |
Wertpapier | MYGN |
Börse | IEX |
Typ | Aktie |
Andere Handelsplätze
Börse | Aktuell | Volumen | |
---|---|---|---|
NASDAQ | 23,1200 | ![]() |
524.579 |
IEX | 23,11 | ![]() |
27.818 |
Cboe US | 23,11 | ![]() |
25.462 |
Hannover | 19,500 | ![]() |
0 |
Frankfurt | 19,4950 | ![]() |
0 |
Berlin | 19,495 | ![]() |
0 |
München | 19,690 | ![]() |
0 |
Hamburg | 19,500 | ![]() |
0 |
Düsseldorf | 19,665 | ![]() |
0 |
Stuttgart | 19,500 | ![]() |
0 |
Lang & Schwa.. | 21,320 | ![]() |
|
gettex | 21,630 | ![]() |
|
Quotrix | 19,5900 | ![]() |
|
Xetra | 19,810 | 0 | |
TradeGate | 20,860 | 10 | |
London Domes.. | 22,06 | 100 |
Nachrichten
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
14.03.2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
12.03.2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
08.03.2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
02.03.2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
24.02.2022 / 15:00 - GlobeNewswire
Persönlicher Bereich
Um Push Kurse zu aktivieren klicken Sie auf
im Header.
